Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Liv Jentzsch"'
Autor:
Marion Subklewe, Veit Bücklein, Cecilia Carpio, Frederick L Locke, Andreas Mackensen, Dimitrios Mougiakakos, Michael von Bergwelt-Baildon, Pere Barba, Wolfgang Bethge, Kai Rejeski, Ariel Perez, Gloria Iacoboni, Olaf Penack, Liv Jentzsch, Grace Johnson, Brian Arciola, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Michael D Jain
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/400a6f8385c04652b2cf390c6b50b0b8
Autor:
Kai Rejeski, Ariel Perez, Gloria Iacoboni, Olaf Penack, Veit Bücklein, Liv Jentzsch, Dimitrios Mougiakakos, Grace Johnson, Brian Arciola, Cecilia Carpio, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Frederick L Locke, Michael von Bergwelt-Baildon, Andreas Mackensen, Wolfgang Bethge, Pere Barba, Michael D Jain, Marion Subklewe
Publikováno v:
Scientia
Hematologic neoplasms; Receptors; Chimeric antigen Neoplasias hematológicas; Receptores; Antígeno quimérico Neoplàsies hematològiques; Receptors; Antigen quimèric Background CD19-directed chimeric antigen receptor T-cell therapy (CAR-T) represe
Autor:
Christian Schmidt, Marion Subklewe, Michael D. Jain, Pierre Sesques, Boris Fehse, Liv Jentzsch, Gilles Salles, Frederick L. Locke, Philipp Karschnia, Martin Dreyling, Francis Ayuk, Eva Hoster, Josephine Ackermann, Michael von Bergwelt-Baildon, Andreas Mackensen, Viktoria Blumenberg, Carolina Berger, Oliver Weigert, Christoph Faul, Emmanuel Bachy, Laurent Jallades, Wolfgang Bethge, L. Frölich, Veit Buecklein, Ariel Perez Perez, Dimitrios Mougiakakos, Kai Rejeski
Publikováno v:
Blood
Hematotoxicity represents a frequent chimeric antigen receptor (CAR) T-cell–related adverse event and remains poorly understood. In this multicenter analysis, we studied patterns of hematopoietic reconstitution and evaluated potential predictive ma
Autor:
Brian Arciola, Frederick L. Locke, Cecilia Carpio, Marion Subklewe, Pere Barba, Gloria Iacoboni, Michael von Bergwelt, Dimitrios Mougiakakos, Michael D. Jain, Andreas Mackensen, Ariel Perez-Perez, Olaf Penack, Kai Rejeski, Viktoria Blumenberg, Grace Johnson, Veit Buecklein, Eva Hoster, Liv Jentzsch, Lars Bullinger, Wolfgang Bethge
Publikováno v:
Blood. 138:3852-3852
Introduction: Prolonged cytopenias and infectious complications substantially contribute to the toxicity burden of CD19-directed CAR T-cell therapy (CAR-T). The latter represent the most common cause of non-relapse mortality after CAR-T. We have rece
Autor:
Marion Subklewe, Michael von Bergwelt, Veit Buecklein, Viktoria Blumenberg, Wolfgang Bethge, Liv Jentzsch, Kai Rejeski, Francis Ayuk, Carolina Berger, Christoph Faul, Christian Schmidt, Tobias Feuchtinger, Semjon Willier
Publikováno v:
Blood. 136:41-42
Introduction: Genetically engineered CD19-specific CAR T-lymphocytes have emerged as a powerful new class of immunotherapeutic agents in relapsed/refractory B-cell malignancies. However, their utility is hampered by unique toxicities including prolon